Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis
William T. Harris, Elizabeth Baker, Jennifer S. Guimbellot, Joseph M. Collaco, Michael S. Schechter, Gabriela R. Oates
Topics & Concepts
IvacaftorCystic fibrosisMedicineTobacco smokeSmokeInternal medicineEnvironmental healthCystic fibrosis transmembrane conductance regulatorMeteorologyPhysicsCystic Fibrosis Research AdvancesNematode management and characterization studies